202 related articles for article (PubMed ID: 38379085)
1. Downregulation of praja2 restrains endocytosis and boosts tyrosine kinase receptors in kidney cancer.
Rinaldi L; Chiuso F; Senatore E; Borzacchiello D; Lignitto L; Iannucci R; Donne RD; Fuggi M; Reale C; Russo F; Russo NA; Giurato G; Rizzo F; Sellitto A; Santangelo M; De Biase D; Paciello O; D'Ambrosio C; Amente S; Garbi C; Dalla E; Scaloni A; Weisz A; Ambrosino C; Insabato L; Feliciello A
Commun Biol; 2024 Feb; 7(1):208. PubMed ID: 38379085
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth.
Delle Donne R; Iannucci R; Rinaldi L; Roberto L; Oliva MA; Senatore E; Borzacchiello D; Lignitto L; Giurato G; Rizzo F; Sellitto A; Chiuso F; Castaldo S; Scala G; Campani V; Nele V; De Rosa G; D'Ambrosio C; Garbi C; Scaloni A; Weisz A; Ambrosino C; Arcella A; Feliciello A
Commun Biol; 2022 Aug; 5(1):780. PubMed ID: 35918402
[TBL] [Abstract][Full Text] [Related]
3. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.
Zhou L; Yang H
PLoS One; 2011; 6(9):e23936. PubMed ID: 21949687
[TBL] [Abstract][Full Text] [Related]
4. MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
Luo L; Wei D; Pan Y; Wang QX; Feng JX; Yu B; Kang T; Luo J; Yang J; Gao S
Cancer Commun (Lond); 2023 Jul; 43(7):808-833. PubMed ID: 37378422
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase expression profile in clear cell renal cell carcinoma.
Behbahani TE; Thierse C; Baumann C; Holl D; Bastian PJ; von Ruecker A; Müller SC; Ellinger J; Hauser S
World J Urol; 2012 Aug; 30(4):559-65. PubMed ID: 21969129
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.
Chua BT; Lim SJ; Tham SC; Poh WJ; Ullrich A
Mol Oncol; 2010 Aug; 4(4):323-34. PubMed ID: 20359967
[TBL] [Abstract][Full Text] [Related]
7. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
[TBL] [Abstract][Full Text] [Related]
8. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract][Full Text] [Related]
9. The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling.
Tringali C; Lupo B; Silvestri I; Papini N; Anastasia L; Tettamanti G; Venerando B
J Biol Chem; 2012 Dec; 287(51):42835-45. PubMed ID: 23139422
[TBL] [Abstract][Full Text] [Related]
10. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
11. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma.
An HJ; Song DH; Koh HM; Kim YM; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; Seo DH; Jang SM; Kim DC
Sci Rep; 2019 Sep; 9(1):12656. PubMed ID: 31477752
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Zaman S; Hajiran A; Coba GA; Robinson T; Madanayake TW; Segarra DT; Chobrutskiy BI; Boyle TA; Zhou JM; Kim Y; Mulé JJ; Teer JK; Manley BJ
Eur Urol Focus; 2021 Mar; 7(2):373-380. PubMed ID: 31901438
[TBL] [Abstract][Full Text] [Related]
13. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation.
Haglund K; Sigismund S; Polo S; Szymkiewicz I; Di Fiore PP; Dikic I
Nat Cell Biol; 2003 May; 5(5):461-6. PubMed ID: 12717448
[TBL] [Abstract][Full Text] [Related]
14. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
[TBL] [Abstract][Full Text] [Related]
15. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
Wang S; Yu ZH; Chai KQ
Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
[TBL] [Abstract][Full Text] [Related]
16. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
17. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
18. Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.
Thomasson M; Hedman H; Ljungberg B; Henriksson R
BMC Res Notes; 2012 May; 5():216. PubMed ID: 22554477
[TBL] [Abstract][Full Text] [Related]
19. LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis.
Thomasson M; Hedman H; Guo D; Ljungberg B; Henriksson R
Br J Cancer; 2003 Oct; 89(7):1285-9. PubMed ID: 14520461
[TBL] [Abstract][Full Text] [Related]
20. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.
Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H
Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]